With Serena Williams, Amy Schumer, Andy Cohen, Meghan Trainor and more stars giving the various weight loss medicines a shot, ...

Novo Nordisk has had a difficult year: a tumbling stock price resulting in the biggest leadership shakeup in the company's ...

Novo Nordisk 's ( NVO +2.93%) shareholders must be happy to see 2025 finally come to a close. It was not a good year for the ...

Novo Nordisk has been handed a crucial legal win by China's Supreme Court, which has upheld the company's patent protection ...

As of Dec. 29, Health Canada had received nine submissions seeking approval to make semaglutide, the active ingredient in ...

Novo Nordisk's long-term strategy for weight-loss treatments has earned praise from scientists, even as investors grow ...

Last month, Novo Nordisk won Food and Drug Administration approval for the first GLP-1 pill for weight loss. The medication, ...

The price of weight-loss drugs like Wegovy put them out of reach for most people with obesity, but new arrivals and expiring ...

India is expected to be the witness the fiercest competition in 2026, with Semaglutide's patent expiry in March triggering launches by 10-15 players within the following three months.

Today, Aisling’s doctor calls her the ‘poster girl for Ozempic’ because she’s bucked recent research by the University of ...